SpringerLink
Log in

Gastrointestinal Stromal Tumors, Neuroendocrine Tumors, and Lymphoma

  • Chapter
  • First Online:
The ASCRS Textbook of Colon and Rectal Surgery

  • 4044 Accesses

Abstract

This chapter discusses the three most common nonadenomatous neoplasms of the colon and rectum: gastrointestinal stromal tumors (GISTs), neuroendocrine tumors (NETs), and lymphoma. The presentation, diagnosis, and management of each of these tumors vary based on tumor origin, biology, and prognosis. For each of these tumors, surgery plays a key role in cure, symptom control, palliation, and prevention of complications. A multidisciplinary approach is required for optimal management of these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 74.89
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 106.99
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 139.09
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Mazur MT, Clark HB. Gastric stromal tumors reappraisal of histogenesis. Am J Surg Pathol. 1983;7(6):507–20. https://doi.org/10.1097/00000478-198309000-00001.

    Article  CAS  PubMed  Google Scholar 

  2. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152(5):1259–69.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Joensuu H, Reichardt P, Eriksson M, Hall KS, Vehtari A. Gastrointestinal stromal tumor: a method for optimizing the timing of CT scans in the follow-up of cancer patients. Radiology. 2014;271(1):96–106. https://doi.org/10.1148/radiol.13131040.

    Article  PubMed  Google Scholar 

  4. Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33(5):459–65. https://doi.org/10.1053/hupa.2002.123545.

    Article  PubMed  Google Scholar 

  5. Parab TM, DeRogatis MJ, Boaz AM, et al. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2018;10(1):144–54. https://doi.org/10.21037/jgo.2018.08.20.

    Article  Google Scholar 

  6. Medeiros F, Corless CL, Duensing A, et al. KIT-negative gastrointestinal stromal tumors. Am J Surg Pathol. 2004;28(7):889–94. https://doi.org/10.1097/00000478-200407000-00007.

    Article  PubMed  Google Scholar 

  7. West RB, Corless CL, Chen X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165(1):107–13. https://doi.org/10.1016/S0002-9440(10)63279-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. von Mehren M, Joensuu H. Gastrointestinal stromal tumors. J Clin Oncol. 2018;36(2):136–43. https://doi.org/10.1200/JCO.2017.74.9705.

    Article  Google Scholar 

  9. Reichardt P, Hogendoorn PCW, Tamborini E, et al. Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issues. Semin Oncol. 2009;36(4):290–301. https://doi.org/10.1053/j.seminoncol.2009.06.002.

    Article  CAS  PubMed  Google Scholar 

  10. Heinrich MC. PDGFRA activating mutations in gastrointestinal stromal tumors. Science (80). 2003;299(5607):708–10. https://doi.org/10.1126/science.1079666.

    Article  CAS  Google Scholar 

  11. Mason EF, Hornick JL. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Mod Pathol. 2013;26(11):1492–7. https://doi.org/10.1038/modpathol.2013.86.

    Article  CAS  PubMed  Google Scholar 

  12. Ricci R. Syndromic gastrointestinal stromal tumors. Hered Cancer Clin Pract. 2016;14(1):15. https://doi.org/10.1186/s13053-016-0055-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46. https://doi.org/10.1016/j.canep.2015.10.031.

    Article  PubMed  Google Scholar 

  14. Scherübl H. Management of early asymptomatic gastrointestinal stromal tumors of the stomach. World J Gastrointest Endosc. 2014;6(7):266. https://doi.org/10.4253/wjge.v6.i7.266.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1455–78.

    Article  Google Scholar 

  16. Scarpa M, Bertin M, Ruffolo C, Polese L, D’Amico DF, Angriman I. A systematic review on the clinical diagnosis of gastrointestinal stromal tumors. J Surg Oncol. 2008;98(5):384–92. https://doi.org/10.1002/jso.21120.

    Article  PubMed  Google Scholar 

  17. Kelley K, Byrne R, Lu K. Gastrointestinal stromal tumors of the distal gastrointestinal tract. Clin Colon Rectal Surg. 2018;31(05):295–300. https://doi.org/10.1055/s-0038-1642053.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Stelow EB, Stanley MW, Lai R, Mallery S. Endoscopic ultrasound-guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol. 2003;119(5):703–8. https://doi.org/10.1309/UWUV-Q001-0D9W-0HPN.

    Article  PubMed  Google Scholar 

  19. Eriksson M, Reichardt P, Sundby Hall K, et al. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour – does it increase the risk for tumour cell seeding and recurrence? Eur J Cancer. 2016;59:128–33. https://doi.org/10.1016/j.ejca.2016.02.021.

    Article  PubMed  Google Scholar 

  20. Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby HK. Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine. Br J Surg. 2016;103(6):684–91. https://doi.org/10.1002/bjs.10104.

    Article  PubMed  Google Scholar 

  21. Vernuccio F, Taibbi A, Picone D, et al. Imaging of gastrointestinal stromal tumors: from diagnosis to evaluation of therapeutic response. Anticancer Res. 2016;36(6):2639–48.

    CAS  PubMed  Google Scholar 

  22. Stroszczynski C, Jost D, Reichardt P, et al. Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI. Eur Radiol. 2005;15(12):2448–56. https://doi.org/10.1007/s00330-005-2867-x.

    Article  PubMed  Google Scholar 

  23. Joensuu H, Vehtari A, Riihimäki J, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265–74. https://doi.org/10.1016/S1470-2045(11)70299-6.

    Article  PubMed  Google Scholar 

  24. Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382(9896):973–83. https://doi.org/10.1016/S0140-6736(13)60106-3.

    Article  CAS  PubMed  Google Scholar 

  25. Changchien CR, Wu M-C, Tasi W-S, et al. Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and Immunohistochemical staining. Dis Colon Rectum. 2004;47(11):1922–9. https://doi.org/10.1007/s10350-004-0687-8.

    Article  PubMed  Google Scholar 

  26. Cavnar MJ, Wang L, Balachandran VP, et al. Rectal Gastrointestinal Stromal Tumor (GIST) in the era of Imatinib: organ preservation and improved oncologic outcome. Ann Surg Oncol. 2017;24(13):3972–80. https://doi.org/10.1245/s10434-017-6087-9.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Wilkinson MJ, Fitzgerald JEF, Strauss DC, et al. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib. Br J Surg. 2015;102(8):965–71. https://doi.org/10.1002/bjs.9818.

    Article  CAS  PubMed  Google Scholar 

  28. Corless CL, Ballman KV, Antonescu CR, et al. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014;32(15):1563–70. https://doi.org/10.1200/JCO.2013.51.2046.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Benjamin RS, Casali PG. Adjuvant Imatinib for GI stromal tumors: when and for how long? J Clin Oncol. 2016;34(3):215–8. https://doi.org/10.1200/JCO.2015.64.0102.

    Article  CAS  PubMed  Google Scholar 

  30. Casali PG, Le Cesne A, Poveda Velasco A, et al. Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with Imatinib as an adjuvant: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Tr. J Clin Oncol. 2015;33(36):4276–83. https://doi.org/10.1200/JCO.2015.62.4304.

    Article  CAS  PubMed  Google Scholar 

  31. Joensuu H, Eriksson M, Sundby Hall K, et al. Adjuvant Imatinib for high-risk GI stromal tumor: analysis of a randomized trial. J Clin Oncol. 2016;34(3):244–50. https://doi.org/10.1200/JCO.2015.62.9170.

    Article  CAS  PubMed  Google Scholar 

  32. Raut CP, Espat NJ, Maki RG, et al. Efficacy and tolerability of 5-year adjuvant Imatinib treatment for patients with resected intermediate- or high-risk primary gastrointestinal stromal tumor. JAMA Oncol. 2018;4(12):e184060. https://doi.org/10.1001/jamaoncol.2018.4060.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Du C-Y, Zhou Y, Song C, et al. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China. Eur J Cancer. 2014;50(10):1772–8. https://doi.org/10.1016/j.ejca.2014.03.280.

    Article  PubMed  Google Scholar 

  34. Bauer S, Rutkowski P, Hohenberger P, et al. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib – analysis of prognostic factors (EORTC-STBSG collaborative study). Eur J Surg Oncol. 2014;40(4):412–9. https://doi.org/10.1016/j.ejso.2013.12.020.

    Article  CAS  PubMed  Google Scholar 

  35. Yamanaka T, Takaki H, Nakatsuka A, et al. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor. J Vasc Interv Radiol. 2013;24(3):341–6. https://doi.org/10.1016/j.jvir.2012.11.021.

    Article  PubMed  Google Scholar 

  36. Günter E, Lingenfelser T, Eitelbach F, Müller H, Ell C. EUS-guided ethanol injection for treatment of a GI stromal tumor. Gastrointest Endosc. 2003;57(1):113–5. https://doi.org/10.1067/mge.2003.39.

    Article  PubMed  Google Scholar 

  37. Oberndorfer S. Karzinoide tumoren des dunndarms. Frankf Z Pathol. 1907;1(7):426.

    Google Scholar 

  38. Byrne R, Pommier R. Small bowel and colorectal carcinoids. Clin Colon Rectal Surg. 2018;31(05):301–8. https://doi.org/10.1055/s-0038-1642054.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wiedenmann B, John M, Ahnert-Hilger G, Riecken E-O. Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system. J Mol Med. 1998;76(9):637–47. https://doi.org/10.1007/s001090050261.

    Article  CAS  PubMed  Google Scholar 

  40. Patel N, Barbieri A, Gibson J. Neuroendocrine tumors of the gastrointestinal tract and pancreas. Surg Pathol Clin. 2019;12(4):1021–44. https://doi.org/10.1016/j.path.2019.08.007.

    Article  PubMed  Google Scholar 

  41. Boudreaux JP, Klimstra DS, Hassan MM, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas. 2010;39(6):753–66. https://doi.org/10.1097/MPA.0b013e3181ebb2a5.

    Article  PubMed  Google Scholar 

  42. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72. https://doi.org/10.1200/JCO.2007.15.4377.

    Article  PubMed  Google Scholar 

  43. Korse CM, Taal BG, van Velthuysen M-LF, Visser O. Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry. Eur J Cancer. 2013;49(8):1975–83. https://doi.org/10.1016/j.ejca.2012.12.022.

    Article  PubMed  Google Scholar 

  44. Jetmore AB, Ray JE, Gathright BJ, McMullen KM, Hicks TC, Timmcke AE. Rectal carcinoids. Dis Colon Rectum. 1992;35(8):717–25. https://doi.org/10.1007/BF02050318.

    Article  CAS  PubMed  Google Scholar 

  45. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–59. https://doi.org/10.1002/cncr.11105.

    Article  PubMed  Google Scholar 

  46. Anthony LB, Strosberg JR, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal Neuroendocrine Tumors (NETs). Pancreas. 2010;39(6):767–74. https://doi.org/10.1097/MPA.0b013e3181ec1261.

    Article  PubMed  Google Scholar 

  47. Chung TP, Hunt SR. Carcinoid and neuroendocrine tumors of the colon and rectum. Clin Colon Rectal Surg. 2006;19(2):45–8. https://doi.org/10.1055/s-2006-942343.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Ganim RB, Norton JA. Recent advances in carcinoid pathogenesis, diagnosis and management. Surg Oncol. 2000;9(4):173–9. https://doi.org/10.1016/S0960-7404(01)00007-X.

    Article  CAS  PubMed  Google Scholar 

  49. NCCN. Neuroendocrine tumors. https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf. Accessed February 4, 2020.

  50. Barclay THC, Schapira DV. Malignant tumors of the small intestine. Cancer. 1983;51(5):878–81. https://doi.org/10.1002/1097-0142(19830301)51:5<878::AID-CNCR2820510521>3.0.CO;2-V.

    Article  CAS  PubMed  Google Scholar 

  51. Lucas KJ, Feldman JM. Flushing in the carcinoid syndrome and plasma kallikrein. Cancer. 1986;58(10):2290–3. https://doi.org/10.1002/1097-0142(19861115)58:10<2290::AID-CNCR2820581022>3.0.CO;2-4.

    Article  CAS  PubMed  Google Scholar 

  52. Lips CJ, Lentjes EG, Hoppener JW. The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem. 2003;40(6):612–27. https://doi.org/10.1258/000456303770367207.

    Article  PubMed  Google Scholar 

  53. Fujimura Y, Mizuno M, Takeda M, et al. A carcinoid tumor of the rectum removed by strip biopsy. Endoscopy. 1993;25(06):428–30. https://doi.org/10.1055/s-2007-1010353.

    Article  CAS  PubMed  Google Scholar 

  54. Semelka RC, Custodio CM, Balci NC, Woosley JT. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging. 2000;11(2):141–8. https://doi.org/10.1002/(SICI)1522-2586(200002)11:2<141::AID-JMRI10>3.0.CO;2-U.

    Article  CAS  PubMed  Google Scholar 

  55. Krenning EP, Kooij PPM, Bakker WH, et al. Radiotherapy with a radiolabeled somatostatin analogue, [ 111 In-DTPA-d-Phe 1 ]-Octreotide. Ann N Y Acad Sci. 1994;733(1 Molecular and):496–506. https://doi.org/10.1111/j.1749-6632.1994.tb17300.x

  56. Reubi J, Laissue J, Waser B, Horisberger U, Schaer J. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci. 1994;733(1 Molecular and):122–137. https://doi.org/10.1111/j.1749-6632.1994.tb17262.x

  57. Geijer H, Breimer LH. Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2013;40(11):1770–80. https://doi.org/10.1007/s00259-013-2482-z.

    Article  CAS  PubMed  Google Scholar 

  58. Tirosh A, Kebebew E. The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. Future Oncol. 2018;14(2):111–22. https://doi.org/10.2217/fon-2017-0393.

    Article  CAS  PubMed  Google Scholar 

  59. Onozato Y, Kakizaki S, Iizuka H, Sohara N, Mori M, Itoh H. Endoscopic treatment of rectal carcinoid tumors. Dis Colon Rectum. 2010;53(2):169–76. https://doi.org/10.1007/DCR.0b013e3181b9db7b.

    Article  PubMed  Google Scholar 

  60. Chablaney S, Zator ZA, Kumta NA. Diagnosis and management of rectal neuroendocrine tumors. Clin Endosc. 2017;50(6):530–6. https://doi.org/10.5946/ce.2017.134.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Hay DJ, Curt JR. Carcinoid tumour as a complication of ulcerative colitis. Postgrad Med J. 1979;55(644):430–2. https://doi.org/10.1136/pgmj.55.644.430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Dodd SM. Chronic ulcerative colitis complicated by atypical carcinoid tumour. J Clin Pathol. 1986;39(8):913–6. https://doi.org/10.1136/jcp.39.8.913.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Owen DA, Hwang WS, Thorlakson RH, Walli E. Malignant carcinoid tumor complicating chronic ulcerative colitis. Am J Clin Pathol. 1981;76(3):333–8. https://doi.org/10.1093/ajcp/76.3.333.

    Article  CAS  PubMed  Google Scholar 

  64. Breen EM, Misdraji J. Case 28-2000. Cabot RC, Scully RE, Mark EJ, et al., eds. N Engl J Med 2000;343(11):794–800. doi:https://doi.org/10.1056/NEJM200009143431108.

  65. Rodrigues Â, Castro-Poças F, Pedroto I. Neuroendocrine rectal tumors: main features and management. GE Port J Gastroenterol. 2015;22(5):213–20. https://doi.org/10.1016/j.jpge.2015.04.008.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Kobayashi K, Katsumata T, Yoshizawa S, et al. Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography. Dis Colon Rectum. 2005;48(2):285–91. https://doi.org/10.1007/s10350-004-0765-y.

    Article  PubMed  Google Scholar 

  67. Ford MM. Neuroendocrine tumors of the colon and rectum. Dis Colon Rectum. 2017;60(10):1018–21. https://doi.org/10.1097/DCR.0000000000000917.

    Article  PubMed  Google Scholar 

  68. Strosberg JR, Coppola D, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 2010;39(6):799–800. https://doi.org/10.1097/MPA.0b013e3181ebb56f.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

  70. Nehar D, Lombard-Bohas C, Olivieri S, et al. Interest of chromogranin a for diagnosis and follow-up of endocrine tumours. Clin Endocrinol. 2004;60(5):644–52. https://doi.org/10.1111/j.1365-2265.2004.02030.x.

    Article  CAS  Google Scholar 

  71. Tormey WP, FitzGerald RJ. The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid. Postgrad Med J. 1995;71(839):542–5. https://doi.org/10.1136/pgmj.71.839.542.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Bajetta E, Ferrari L, Martinetti A, et al. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer. 1999;86(5):858–65. https://doi.org/10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8.

    Article  CAS  PubMed  Google Scholar 

  73. Stinner B, Kisker O, Zielke A, Rothmund M. Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg. 1996;20(2):183–8. https://doi.org/10.1007/s002689900028.

    Article  CAS  PubMed  Google Scholar 

  74. Rösch T, Sarbia M, Schumacher B, et al. Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy. 2004;36(9):788–801. https://doi.org/10.1055/s-2004-825838.

    Article  PubMed  Google Scholar 

  75. Yamamoto H. Endoscopic submucosal dissection of early cancers and large flat adenomas. Clin Gastroenterol Hepatol. 2005;3(7):S74–6. https://doi.org/10.1016/S1542-3565(05)00254-5.

    Article  PubMed  Google Scholar 

  76. Kajiyama T, Hajiro K, Sakai M, et al. Endoscopic resection of gastrointestinal submucosal lesions: a comparison between strip biopsy and aspiration lumpectomy. Gastrointest Endosc. 1996;44(4):404–10. https://doi.org/10.1016/S0016-5107(96)70089-5.

    Article  CAS  PubMed  Google Scholar 

  77. Berkelhammer C, Jasper I, Kirvaitis E, Schreiber S, Hamilton J, Walloch J. “Band-snare” resection of small rectal carcinoid tumors. Gastrointest Endosc. 1999;50(4):582–5. https://doi.org/10.1016/S0016-5107(99)70092-1.

    Article  CAS  PubMed  Google Scholar 

  78. Fujishiro M, Yahagi N, Nakamura M, et al. Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar. Gastrointest Endosc. 2006;63(2):243–9. https://doi.org/10.1016/j.gie.2005.08.002.

    Article  PubMed  Google Scholar 

  79. Ono A, Fujii T, Saito Y, et al. Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device. Gastrointest Endosc. 2003;57(4):583–7. https://doi.org/10.1067/mge.2003.142.

    Article  PubMed  Google Scholar 

  80. He L, Deng T, Luo H. Efficacy and safety of endoscopic resection therapies for rectal carcinoid tumors: a meta-analysis. Yonsei Med J. 2015;56(1):72. https://doi.org/10.3349/ymj.2015.56.1.72.

    Article  PubMed  Google Scholar 

  81. Shields CJ, Tiret E, Winter DC. Carcinoid tumors of the rectum: a multi-institutional international collaboration. Ann Surg. 2010;252(5):750–5. https://doi.org/10.1097/SLA.0b013e3181fb8df6.

    Article  PubMed  Google Scholar 

  82. Al Natour RH, Saund MS, Sanchez VM, et al. Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection. J Gastrointest Surg. 2012;16(3):595–602. https://doi.org/10.1007/s11605-011-1786-1.

    Article  PubMed  Google Scholar 

  83. Schindl M, Niederle B, Häfner M, et al. Stage-dependent therapy of rectal carcinoid tumors. World J Surg. 1998;22(6):628–34. https://doi.org/10.1007/s002689900445.

    Article  CAS  PubMed  Google Scholar 

  84. Cestaro G, Amato B, De Rosa M, Bianco T, Compagna R, Massa G, Vigliotti G, MSGM. Neuroendocrine tumors of the rectum: an updated review. Minerva Chir. 2014;69(April):67–71.

    Google Scholar 

  85. Eriksson B, Arnberg H, Öberg K, et al. A polyclonal antiserum against chromogranin A and B – a new sensitive marker for neuroendocrine tumours. Acta Endocrinol. 1990;122(2):145–55. https://doi.org/10.1530/acta.0.1220145.

    Article  CAS  Google Scholar 

  86. Rinke A, Müller H-H, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group. J Clin Oncol. 2009;27(28):4656–63. https://doi.org/10.1200/JCO.2009.22.8510.

    Article  CAS  PubMed  Google Scholar 

  87. Caplin ME, Pavel M, Ćwikła JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371(3):224–33. https://doi.org/10.1056/NEJMoa1316158.

    Article  CAS  PubMed  Google Scholar 

  88. Wolin E, Jarzab B, Eriksson B, et al. Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues. Drug Des Devel Ther. September 2015;5075 https://doi.org/10.2147/DDDT.S84177.

  89. Sun W, Lipsitz S, Catalano P, Mailliard JA, Haller DG. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: eastern cooperative oncology group study E1281. J Clin Oncol. 2005;23(22):4897–904. https://doi.org/10.1200/JCO.2005.03.616.

    Article  CAS  PubMed  Google Scholar 

  90. Schnirer II, Yao JC, Ajani JA. Carcinoid a comprehensive review. Acta Oncol (Madr). 2003;42(7):672–92. https://doi.org/10.1080/02841860310010547.

    Article  Google Scholar 

  91. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver. J Am Coll Surg. 2003;197(1):29–37. https://doi.org/10.1016/S1072-7515(03)00230-8.

    Article  PubMed  Google Scholar 

  92. Christante D, Pommier S, Givi B, Pommier R. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. Surgery. 2008;144(6):885–94. https://doi.org/10.1016/j.surg.2008.08.037.

    Article  PubMed  Google Scholar 

  93. Gedaly R. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors. Arch Surg. 2011;146(8):953. https://doi.org/10.1001/archsurg.2011.186.

    Article  PubMed  Google Scholar 

  94. Shen C, Yin Y, Chen H, et al. Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems. Oncotarget. 2017;8(13):22123–34. https://doi.org/10.18632/oncotarget.13641.

    Article  PubMed  Google Scholar 

  95. Scherübl H, Klöppel G. Neuroendokrine Neoplasien des Rektums auf dem Vormarsch – ein Update. Z Gastroenterol. 2009;47(04):365–71. https://doi.org/10.1055/s-2008-1027930.

    Article  PubMed  Google Scholar 

  96. Surveillance, Epidemiology, and End Results Program. National Cancer Institute. https://seer.cancer.gov. Published 2006. Accessed February 4, 2020.

  97. Zighelboim J, Larson MV. Primary colonic lymphoma: clinical presentation, histopathologic features, and outcome with combination chemotherapy. J Clin Gastroenterol. 1994;18(4):291–7. https://doi.org/10.1097/00004836-199406000-00007.

    Article  CAS  PubMed  Google Scholar 

  98. Doolabh N, Anthony T, Simmang C, et al. Primary colonic lymphoma. J Surg Oncol. 2000;74(4):257–62. https://doi.org/10.1002/1096-9098(200008)74:4<257::AID-JSO3>3.0.CO;2-U.

    Article  CAS  PubMed  Google Scholar 

  99. Kang H, O’Connell JB, Leonardi MJ, Maggard MA, McGory ML, Ko CY. Rare tumors of the colon and rectum: a national review. Int J Color Dis. 2007;22(2):183–9. https://doi.org/10.1007/s00384-006-0145-2.

    Article  Google Scholar 

  100. Papamichael K, Lin S, Moore M, Papaioannou G, Sattler L, Cheifetz AS. Infliximab in inflammatory bowel disease. Ther Adv Chronic Dis. 2019;10(Table 2):204062231983844. https://doi.org/10.1177/2040622319838443

  101. Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015;13(5):847–858.e4. https://doi.org/10.1016/j.cgh.2014.05.015.

    Article  CAS  PubMed  Google Scholar 

  102. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005;54(8):1121–5. https://doi.org/10.1136/gut.2004.049460.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Henry CBR. Primary lymphoma of the large intestine. Am Surg. 1988;54(5):262–6.

    CAS  PubMed  Google Scholar 

  104. Devaney K, Jaffe ES. The surgical pathology of gastrointestinal Hodgkin’s disease. Am J Clin Pathol. 1991;95(6):794–801. https://doi.org/10.1093/ajcp/95.6.794.

    Article  CAS  PubMed  Google Scholar 

  105. Gay ND, Chen A, Okada CY. Colorectal lymphoma: a review. Clin Colon Rectal Surg. 2018;31(5):309–16. https://doi.org/10.1055/s-0038-1642048.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Myung SJ, Joo KR, Yang SK, et al. Clinicopathologic features of ileocolonic malignant lymphoma: analysis according to colonoscopic classification. Gastrointest Endosc. 2003;57(3):343–7. https://doi.org/10.1067/mge.2003.135.

    Article  PubMed  Google Scholar 

  107. Rohatiner A, d’Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5(5):397–400. https://doi.org/10.1093/oxfordjournals.annonc.a058869.

    Article  CAS  PubMed  Google Scholar 

  108. Rosenberg S. Validity of the Ann Arbor staging classification for the non-Hodgkin’s lymphomas. Cancer Treat Rep. 1977;61(6):1023–7.

    CAS  PubMed  Google Scholar 

  109. Moormeier JA, Williams SF, Golomb H. The staging of non-Hodgkin’s lymphomas. Semin Oncol. 1990;17(01):43–50.

    CAS  PubMed  Google Scholar 

  110. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31:1860–1.

    CAS  PubMed  Google Scholar 

  111. Lee J, Kim WS, Kim K, et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res. 2007;31(3):359–64. https://doi.org/10.1016/j.leukres.2006.06.018.

    Article  PubMed  Google Scholar 

  112. Kim SJ, Kang HJ, Kim JS, et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. 2011;117(6):1958–65. https://doi.org/10.1182/blood-2010-06-288480.

    Article  CAS  PubMed  Google Scholar 

  113. **nai D, Iwasa Z, Watanuki T. Malignant lymphoma of the large intestine —operative results in Japan. Jpn J Surg. 1983;13(4):331–6. https://doi.org/10.1007/BF02469515.

    Article  CAS  PubMed  Google Scholar 

  114. Lai Y-L, Lin J-K, Liang W-Y, Huang Y-C, Chang S-C. Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol. 2011;104(3):265–8. https://doi.org/10.1002/jso.21927.

    Article  PubMed  Google Scholar 

  115. Quayle FJ, Lowney JK. Colorectal lymphoma. Clin Colon Rectal Surg. 2006;19(2):49–53. https://doi.org/10.1055/s-2006-942344.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Devine RM, Beart RW, Wolff BG. Malignant lymphoma of the rectum. Dis Colon Rectum. 1986;29(12):821–4. https://doi.org/10.1007/BF02555355.

    Article  CAS  PubMed  Google Scholar 

  117. Takenaka R, Tomoda J, Sakata T, et al. Mucosa-associated lymphoid tissue lymphoma of the rectum that regressed spontaneously. J Gastroenterol Hepatol. 2000;15(3):331–5. https://doi.org/10.1046/j.1440-1746.2000.02086.x.

    Article  CAS  PubMed  Google Scholar 

  118. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Stage I and II malt lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys. 2001;50(5):1258–64. https://doi.org/10.1016/S0360-3016(01)01549-8.

    Article  CAS  PubMed  Google Scholar 

  119. Okamura T, Suga T, Iwaya Y, et al. Helicobacter pylori-negative primary rectal MALT lymphoma: complete remission after radiotherapy. Case Rep Gastroenterol. 2012;6(2):319–27. https://doi.org/10.1159/000339461.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Orita M, Yamashita K, Okino M, Enoki T, Noshima S, Morita N, Esato K. A case of MALT (mucosa-associated lymphoid tissue) lymphoma occurring in the rectum. Hepato-Gastroenterology. 1999;46(28):2352–4.

    CAS  PubMed  Google Scholar 

  121. Kiesewetter B, Ferreri AJM, Raderer M. Chemoimmunotherapy for mucosa-associated lymphoid tissue-type lymphoma: a review of the literature. Oncologist. 2015;20(8):915–25. https://doi.org/10.1634/theoncologist.2015-0109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Shia J, Teruya-Feldstein J, Pan D, et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol. 2002;26(2):216–24. https://doi.org/10.1097/00000478-200202000-00008.

    Article  PubMed  Google Scholar 

  123. Kim YH, Lee JH, Yang SK, et al. Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) study. Dig Dis Sci. 2005;50(12):2243–7. https://doi.org/10.1007/s10620-005-3041-7.

    Article  PubMed  Google Scholar 

  124. Romaguera J, Hagemeister FB. Lymphoma of the colon. Curr Opin Gastroenterol. 2005;21(1):80–4.

    PubMed  Google Scholar 

  125. Xu G, Wang P, **ao Y, Wu X, Lin G. Local resection of rectal neuroendocrine tumor with first clinical manifestation of giant liver metastasis by transanal endoscopic microsurgery: a case report. Med (United States). 2017;96(50). https://doi.org/10.1097/MD.0000000000009153

Download references

Author information

Authors and Affiliations

  1. University of Massachusetts Medical School, Department of Surgery, Division of Colon and Rectal Surgery, Worcester, MA, USA

    Karim Alavi

  2. Jewish General Hospital, Division of Colorectal Surgery, Montreal, QC, Canada

    Marylise Boutros

Authors
  1. Karim Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marylise Boutros
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA

    Scott R. Steele

  2. Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA

    Tracy L. Hull

  3. University of Chicago Medical Center, Chicago, IL, USA

    Neil Hyman

  4. Department of Surgery, University of Massachusetts Medical School, Worcester, MA, USA

    Justin A. Maykel

  5. Division of Gastrointestinal Surgery, University of Florida, Gainesville, FL, USA

    Thomas E. Read

  6. Department of Colon and Rectal Surgery, Ochsner Clinic, New Orleans, LA, USA

    Charles B. Whitlow

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alavi, K., Boutros, M. (2022). Gastrointestinal Stromal Tumors, Neuroendocrine Tumors, and Lymphoma. In: Steele, S.R., Hull, T.L., Hyman, N., Maykel, J.A., Read, T.E., Whitlow, C.B. (eds) The ASCRS Textbook of Colon and Rectal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-66049-9_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-66049-9_34

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-66048-2

  • Online ISBN: 978-3-030-66049-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation